http://www.functionalmedicineuniversity.

com
How to Stop or Slow Down Stroke Damage

Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N., M.S.

I can remember like yesterday, a dear friend in the prime of his life suffered a massive
stroke. My wife and I went to the hospital every day for a few weeks and watched the
medical team work to keep him alive. I will say that there is a time and place for
appropriate medical intervention.
My friend did survive only to be left blind and paralyzed on the right side of his body.
Life has not been same since his stroke.
I pray you never ignore any of the early warning signs of stroke, such as

sudden dizziness, severe headache, loss of vision, inability to speak or

even not knowing where you are, or sudden uselessness of a limb.
On the positive side, there are a growing number of people who have made a 90% to
100% recovery by correcting their biochemistry via the results found in doing a
timely Cardio/ION test.

The sad fact is these people are in the minority simply because traditional
medicine does not look at human biochemistry as it relates to stroke recovery.
As it now stands in standard medical care thrombolytic therapy is the only treatment for
ischemic stroke.
The most commonly used drug for thrombolytic therapy is tissue plasminogen
activator (T-PA). T-PA works best to help people with strokes caused by clots (ischemic
strokes) when it is given right away after stroke symptoms begin. Ideally, one should
receive thrombolytic medications within the first 90 minutes after arriving at the hospital
for treatment.
Unfortunately a 2008 paper published in the New England Journal of Medicine stated
that due to its narrow therapeutic window and complexity of administration, only 3-5% of
patients benefit from plasminogen activator (T-PA) therapy. The paper further
commented that the current treatment for stroke patients is simply not enough to give
good results.
A viable and medically documented answer that sadly is not addressed for the stroke
victim is the recommendation of DHA (docosahexaenoic acid, an omega-3 fatty acid
that is in cod liver oil).
Yes, you read that right.

A recent study showed that when they created strokes in experimental

animals, if they gave DHA this cut the size of the infarct (the area of brain
that is damaged) by up to 77%! In other words the brain's area of
stroke damage was only one quarter of its original
size.

Giving DHA cut the size of the infarct (the area of brain

that is damaged) by up to 77%!

Now that is amazing!

--

Now there is something you MUST know to make this effective and that is DHA needs to

be given within five hours of the stroke.

If you want to take a pro-active role in your cardiovascular health it would be wise to
have your fatty acids checked by your physician.
What you want to see is your docosahexaenoic acid levels in the 5th quintile

This study emphasized the significance of doctors giving as little as 500 mg of DHA

as soon as someone is diagnosed with a stroke.

This amount not only cut the area of damage by three-fourths, but speeded up
recovery and improved many other parameters, such as reducing the amount of
swelling in the brain, and much more.
You need to know that the accumulation of phthalates (plastics), statin drugs,
chemotherapy as well as calcium channel blockers (high blood pressure medication) all
damage DHA conversion in the body.
If you have any friends hospitalized with sudden stroke, make sure doctors give

them DHA within five hours, which may cut the size of brain damage 77%!

Of course don't forget to protect yourself with the benefit of DHA.

To be quite honest, if you want to do something good for yourself and really
take a pro-active role in your cardiovascular health ask your doctor to order
a CardioIon Test. The fatty acid test is part of the CardioION test.
Click Here
Click Here

to read more information about the Fatty Acid Test

to read more information about the CardioIon Test

References:
Belayev, et al, Docosahexaenoic acid therapy of experimental ischemic stroke, Transl

Stroke Res, 2:33-41, 2011

Lukiw WJ, et al, A role for docosahexaenoic acid derived neuroprotectin D1 in the neural
cell survival and Alzheimer's disease, J Clin Invest 115:2774-83, 2005

Ward RE, et al, Docosahexaenoic acid prevents white matter damage

following spinal cord injury, J Neurotrauma 27:1-12, 2010
Belayev L, et al, Robust docosahexaenoic acid mediated neuroprotection in at
model of transient focal cerebral ischemia, Stroke 40:3121-6, 2009
Leyden P, Thrombolytic therapy for acute stroke -- -- not a moment to lose,
New Engl J Med 359:1393-5, 2008
Bazan NG, Neuroprotective D1-mediated anti-inflammatory and survival
signaling in stroke, retinal degeneration, and Alzheimer's disease, J Lipid Res,
50: S400-5, 2009
Akbar M, et al, Docosahexaenoic acid: a positive modulator of Akt signaling in
neuronal survival, Proc Natl Acad Sci USA 102:10858-63, 2005
Rogers Sherry, Total Wellness, Prestige Publishing, November 2011
Mukherjee PK, et al, Neuroprotective D1: a docosahexaenoic acid derived
docosatriene protects human retinal pigment epithelial cells from oxidative
stress, Proc Natl Acad Sci USA 101:8491-6, 2004
Before starting any treatment Dr. Grisanti recommends that you have thorough
knowledge of the science of functional medicine. Visit
to find
practitioners thoroughly trained in functional medicine. Look for practitioners who have
successfully completed the Functional Medicine University's Certification Program
(CFMP).
Functional medicine embraces the totality of the regulatory functions of the body. It
encompasses all of the biophysical, biochemical, enzymatic, endocrine, immunological,
and bioenergetic regulatory capacities. Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N.,
M.S.
www.FunctionalMedicineUniversity.com